Search results for: Adrian Towse
Filter search results
Making Outcome-based Payments a Reality in the NHS: A Research Collaboration between OHE, RAND Europe and King’s College London
15 May 2018
…through adaptive pathways, analysing data governance requirements for real-world data, and using real-world evidence to facilitate managed entry agreements. Adrian Towse and Nancy Devlin will apply their expertise on value-based…
OHE’s Director of Research, Professor Nancy Devlin, to Take up New Role at the University of Melbourne
19 September 2018
…existing collaborations in the UK and elsewhere – to develop a research programme of relevance to health care decision makers in Australia and internationally. Adrian Towse, OHE’s Director, said, I…
OHE Achievements in 2018
27 December 2018
…from Adrian Towse, who becomes Director Emeritus and Senior Research Fellow, as well as Olga Rozanova and Charlotte Davies. We are sorry to lose OHE’s Deputy Director and Head of…
HTA in Japan: Failing to Meet International Good Practice?
15 March 2019
…a QALY-based system. It could lead the world in doing this. Funding declaration and disclaimer: Adrian Towse’s participation in the PhRMA press conference was funded by PhRMA. The views expressed…
Moving the Needle on Value – OHE Launches Research on US Value-Based Healthcare
10 June 2019
…who were invited to share their thoughts on the topic. OHE’s Adrian Towse summarised the short talks and closed the event by inviting attendees to collaborate with OHE on our…
OHE at the 2019 Spanish Health Economics Association (AES) Conference
5 June 2019
…of innovative medicines: the case of risperidone and second-generation antipsychotics This study, co-authored by Mikel Berdud, Bernarda Zamora, and Adrian Towse, aims to guide access decisions and drive the discussion…
Unpacking the Black Box of Payer Policy: A Demand-Side Approach for Equitable Uptake of Cost-Effective Health Innovation
21 February 2020
…Note published by the Center for Global Development available here, authors Kalipso Chalkidou, Adrian Towse and Rachel Silverman argue that neither (i) current limited private sector markets in MLICs, nor (ii) donor push funding is delivering. The current model…
Biosimilars: How Much Entry and Price Competition Will Result?
1 December 2010
…impact. Chapter authors include Profs Bengt Jönsson (Stockholm School of Economics), Prof Henry Grabowski (Duke University), Prof Adrian Towse and Dr. Jorge Mestre-Ferrandiz (OHE), Prof Richard G. Frank (Harvard Medical…
European Medicines Pricing and Reimbursement: Now and the Future
1 January 2007
…Pricing and reimbursement policies in Spain: current and future trends; Overview Contributors: Claude Le Pen, J-Mattias von der Schulenburg, Martina Garau, Adrian Towse, Livio Garattini, Joan Costa-i-Font, Patricia Danzon 2007…